Ondine Biomedical Inc (LON:OBI)
15.00p
Spriggl Score: Moderate— see the number + sub-scores with a free Spriggl account
Last 30 trading days
Spriggl AI Verdict
“Phase three trial delay heightens extreme cash burn risk against minimal revenue generation.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Ondine Biomedical Inc
Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its primary product is Steriwave, which enables rapid elimination of pathogens associated with healthcare-associated infecti…
- Sector:
- Healthcare
- Industry:
- Biotechnology
- Market Cap:
- £77.9M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
Sign up for a free Spriggl account to unlock the full Spriggl Score breakdown, screener, watchlist, and AI investment analysis on Ondine Biomedical Inc and 1,600+ UK and US stocks.
Start free